Global Monogenetic Disorders Testing Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Monogenetic Disorders Testing Market Research Report 2024
According to Mendel's Laws, the monogenetic disorders are inherited because of a single defective gene on the autosomes. The monogenic disorders are caused by single mutated gene which can be present on single or both chromosomes. Females and males are equally affected by this disorder due to the conditions on the autosomes. Some of the tests are available for the mainstream of the common monogenic disorders such as Cystic fibrosis, sickle cell anemia, SCID, Tay-sachs disease, polycystic kidney disorder, Gaucher's disease, Huntington's disease, neurofibromatosis, thalassaemia and familial hypercholesterolemia. There are several test performed to treat with the monogenic disorders such as diagnostic testing, carrier testing, predictive & pre-symptomatic testing, prenatal testing and new-born screening.
According to MRAResearch’s new survey, global Monogenetic Disorders Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Monogenetic Disorders Testing market research.
North America clearly dominates the global monogenetic disorders testing market due to high degree of intelligence and awareness regarding to the monogenic disorders testing procedures. The companies are focused on introducing the procedures with innovative technology, Europe is expected to hold the second large market followed by Asia-Pacific region.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Monogenetic Disorders Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Celera Group
Abbott
Thermo Fisher Scientific
ELITech Group
Quest
AutoGenomics
PerkinElmer
Roche
Bio-Rad
Transgenomic
Segment by Type
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive & Pre-Symptomatic Testing
Prenatal Testing
Others
Hospitals
Specialized Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Monogenetic Disorders Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Monogenetic Disorders Testing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Monogenetic Disorders Testing market research.
North America clearly dominates the global monogenetic disorders testing market due to high degree of intelligence and awareness regarding to the monogenic disorders testing procedures. The companies are focused on introducing the procedures with innovative technology, Europe is expected to hold the second large market followed by Asia-Pacific region.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Monogenetic Disorders Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Celera Group
Abbott
Thermo Fisher Scientific
ELITech Group
Quest
AutoGenomics
PerkinElmer
Roche
Bio-Rad
Transgenomic
Segment by Type
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive & Pre-Symptomatic Testing
Prenatal Testing
Others
Segment by Application
Hospitals
Specialized Clinics
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Monogenetic Disorders Testing report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source